Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

913 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
What do adult outpatients included in clinical trials know about the investigational drugs being assessed: A cross-sectional study in France.
Fronteau C, Paré M, Benoit P, Tollec S, Hamon C, Schwiertz V, Maillard C, Cransac A, Volteau C, Huon JF, Burgeot V, Tching-Sin M, Guérin C, Flet L. Fronteau C, et al. Among authors: guerin c. PLoS One. 2019 Aug 13;14(8):e0220383. doi: 10.1371/journal.pone.0220383. eCollection 2019. PLoS One. 2019. PMID: 31408456 Free PMC article.
Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).
Zerbit J, Detroit M, Chevret S, Pene F, Luyt CE, Ghosn J, Eyvrard F, Martin-Blondel G, Sarton B, Clere-Jehl R, Moine P, Cransac A, Andreu P, Labruyère M, Albertini L, Huon JF, Roge P, Bernard L, Farines-Raffoul M, Villiet M, Venet A, Dumont LM, Kaiser JD, Chapuis C, Goehringer F, Barbier F, Desjardins S, Benzidi Y, Abbas N, Guerin C, Batista R, Llitjos JF, Kroemer M. Zerbit J, et al. Among authors: guerin c. J Clin Med. 2022 Nov 4;11(21):6545. doi: 10.3390/jcm11216545. J Clin Med. 2022. PMID: 36362773 Free PMC article.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.
Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J; ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group. Tubiana R, et al. Clin Infect Dis. 2013 Sep;57(6):891-902. doi: 10.1093/cid/cit390. Epub 2013 Jun 12. Clin Infect Dis. 2013. PMID: 23766338 Clinical Trial.
[Telomeres and lung].
Guérin C, Crestani B, Dupin C, Kawano-Dourado L, Ba I, Kannengiesser C, Borie R. Guérin C, et al. Rev Mal Respir. 2022 Sep;39(7):595-606. doi: 10.1016/j.rmr.2022.03.011. Epub 2022 Jun 14. Rev Mal Respir. 2022. PMID: 35715316 Review. French.
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients.
Nguyen Y, Flahault A, Chavarot N, Melenotte C, Cheminant M, Deschamps P, Carlier N, Lafont E, Thomas M, Flamarion E, Lebeaux D, Charlier C, Rachline A, Guérin C, Ratiney R, Touchard J, Péré H, Rozenberg F, Lanternier F, Arlet JB, Avouac J, Boussaud V, Guillemain R, Vignon M, Thervet E, Scemla A, Weiss L, Mouthon L; AP-HP-Centre Monoclonal Antibodies Working Group. Nguyen Y, et al. Among authors: guerin c. Clin Microbiol Infect. 2022 Dec;28(12):1654.e1-1654.e4. doi: 10.1016/j.cmi.2022.07.015. Epub 2022 Aug 1. Clin Microbiol Infect. 2022. PMID: 35926762 Free PMC article.
913 results